On Friday, Norfolk Southern Corp. (NYSE:NSC)’s shares declined -0.60% to $81.11.
Deborah H. Butler, executive vice president planning and chief information officer of Norfolk Southern Corp. (NSC), has declared her intention to retire effective Oct. 1, 2015, President and CEO Jim Squires said recently.
Butler joined Norfolk Southern in 1978 as a customer account auditor. She served in positions of increasing responsibility in operations before being named assistant vice president transportation customer services in 2000 and vice president customer service in 2002. She has served as chairman of the board of Thoroughbred Technology and Telecommunications LLC, an NS partner, and as a board member of TTX Company Inc., which provides railcars and related freight car administration services to the rail industry.
Norfolk Southern Corporation, together with its auxiliaries, engages in the rail transportation of raw materials, intermediate products, and finished goods. As of December 31, 2014, it operated about 20,000 miles of road in 22 states and the District of Columbia. The company also operates planned passenger trains; transports overseas freight through various Atlantic and Gulf Coast ports; and provides logistics services.
HCP, Inc. (NYSE:HCP)’s shares gained 0.21% to $38.03.
HCP (HCP) declared that its Board of Directors declared a quarterly common stock cash dividend of $0.565 per share. The dividend will be paid on August 25, 2015 to stockholders of record as of the close of business on August 10, 2015.
HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. It primarily invests in properties serving the healthcare industry counting sectors of healthcare such as senior housing, life science, medical office, hospital and skilled nursing. The fund also invests in mezzanine loans and other debt instruments.
At the end of Friday’s trade, Brocade Communications Systems, Inc. (NASDAQ:BRCD)‘s shares surged 0.05% to $10.14.
Brocade® ( BRCD) plans to report its financial results for its third quarter 2015 on Thursday, August 20 following the close of the market. The earnings declarement in addition to the prepared materials for the conference call will be accessible shortly after 1 p.m. PT (4 p.m. ET) at www.brcd.com and will be furnished to the SEC on form 8-K. The earnings declarement will also be distributed by Marketwired.
Brocade Communications Systems, Inc. provides storage area networking (SAN) and Internet protocol networking solutions for businesses and organizations worldwide. It operates through SAN Products, IP Networking Products, and Global Services segments. The SAN Products segment offers infrastructure products and solutions, such as fiber channel SAN backbones, directors, fabrics, and embedded switches that assist customers in the development and delivery of storage and server consolidation, disaster recovery and data security, and compliance issues regarding data administration; and fabric extension, switching, and routing solutions.
Raptor Pharmaceutical Corp. (NASDAQ:RPTP), ended its Friday’s trading session with 1.38% gain, and closed at $13.94.
Raptor Pharmaceutical Corp. (RPTP) declared financial results for the three and six months ended June 30, 2015 and offered an update on recent corporate developments.
Summary
Global net product sales for PROCYSBI(R) (cysteamine bitartrate) delayed-release capsules were $23.3 million for the second quarter ended June 30, 2015 contrast to $16.3 million for the same period in 2014, representing a growth of 43% year over year.
Raptor stated a net loss on a GAAP basis of $13.9 million for the second quarter, or $0.17 per share.
Cash and cash equivalents were $193.0 million while short-term investments were $27.5 million as of June 30, 2015. Cash balances were bolstered by $92.0 million in net proceeds from an underwritten public offering accomplished in April.
Raptor Pharmaceutical Corp., a biopharmaceutical company, focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. The company offers PROCYSBI, a delayed-release capsule, which is used for the administration of nephropathic cystinosis in adults, in addition to in six years and older children in the United States, in the 28 member states of the European Union, Norway, Liechtenstein, and Iceland. Its clinical development programs comprise RP103 that is used as a treatment for Huntington’s disease; RP103 as a treatment for non-alcoholic fatty liver disease in children; and RP103 as a treatment for mitochondrial disorders, counting Leigh syndrome.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
